Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB26FDS54
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,216
Award facts
- Contract value 100% obligated
- $51,216.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of XGEVA 120 mg/1.7 mL vials with a ceiling value of $51,216.27 under a firm fixed-price contract type. This award represents a non-set-aside competitive procurement and is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025.
XGEVA (denosumab) is a bone-protective pharmaceutical commonly used in oncology and musculoskeletal treatment regimens. This delivery order reflects AmerisourceBergen's critical role as a pharmaceutical prime vendor supporting military healthcare systems and other federal medical supply chains. The company's comprehensive IDC with DLA enables the firm to supply a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare customers globally. AmerisourceBergen's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its established capability to meet rigorous federal procurement standards for essential medical commodities.
Quick answers
Who was awarded contract SPE2DB26FDS54?
SPE2DB26FDS54 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FDS54 worth?
The government has obligated $51,216 on SPE2DB26FDS54.
Is contract SPE2DB26FDS54 an order under another contract?
Yes. SPE2DB26FDS54 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDS54 competed?
The extent of competition for SPE2DB26FDS54 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award